UNSPSC 51241306: Alcloxa

This classification denotes an astringent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 18B8O9DQA2. European Medicines Agency schedules Alcloxa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05301MIG. Alcloxa generally arises in the molecular formula C4H5N4O3.2AL.CL.4HO. The term ALCLOXA is an International Non-Proprietary Name or INN. ALCLOXA is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule alcloxa under HS 29332100 and SITC 51572. As of Q4 2014, ALCLOXA remains the US FDA Preferred Term for this commodity. Alcloxa bears US NLM identifiers UMLS ID C0771150 and NCI Concept Code C76518. SMILES: C1(C(=O)NC(=O)N1)NC(=O)N[Al]Cl.O.O.O.O.[Al].

UNSPSC 51241306 Alcloxa, a Commodity code, does not reflect what state and local governments are actually procuring under this designation. The recent solicitations tagged with this code cover liquid aluminum sulfate for wastewater treatment chemical processing and medical aid supplies for fire rescue operations — neither of which aligns with alcloxa, a pharmaceutical active ingredient. The mismatch suggests a tagging error in the source data rather than genuine activity under this Commodity code.

The City of Austin issued IFB 2200 CSH1061 in July 2026 seeking liquid aluminum sulfate (alum) for phosphorus removal at its wastewater treatment facility, with bids due August 25, 2026, and the City of Tampa issued ITB 25-P-00157 in April 2026 for medical aid supplies including antiseptic sprays, hydrogen peroxide, and bandages for the Fire Rescue Department. These opportunities fall under different UNSPSC families — chemical treatment agents and medical consumables, respectively — and do not represent procurement activity in the alcloxa category itself. No recent state and local contract opportunities show legitimate demand for alcloxa under this Commodity code.